임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 1/2상모집 중· Hemophilia AA Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
리드: 로슈
- 4상모집 중· Presumed Ocular HistoplasmosisA Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome
협력: 로슈
- 2상모집 중· HER2-positive Metastatic Breast CancerHER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
협력: 로슈
- 1상모집 중· Relapsed/Refractory Multiple MyelomaA Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
리드: 로슈
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 2상모집 중· Rheumatoid ArthritisAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
리드: 로슈
- 4상모집 중· Hepatocellular CarcinomaAtezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
협력: 로슈
- 1/2상모집 중· Advanced Prostate CancerA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
리드: 로슈
- 3상모집 중· Moderately to Severely Active Ulcerative ColitisA Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 1상모집 중· Stable Coronary Artery DiseaseA Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
리드: 로슈
- 1/2상모집 중· Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
협력: 로슈
- 2상모집 중· Metastatic Castration-Resistant Prostate CancerA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 로슈
- 단계 미표기모집 중· Early-stage HER2+ Breast CancerA Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization
리드: 로슈
- 2상모집 중· Chronic Obstructive Pulmonary Disease (COPD)Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
협력: 로슈
- 1상모집 중· Extensive Stage Small Cell Lung Cancer (ES-SCLC)Iadademstat + SBRT With Atezo in ES-SCLC
협력: 로슈
- 2상모집 중· Acute Ischemic Stroke From Large Vessel OcclusionIntra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
협력: 로슈
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
협력: 로슈
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
리드: 로슈
- 1상모집 중· Huntington's DiseaseA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
리드: 로슈
- 단계 미표기모집 중· Multiple SclerosisPeople With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
협력: 로슈
- 단계 미표기모집 중· Diabetic NephropathiesTransformative Research in Diabetic Nephropathy 2.0
협력: 아스트라제네카, GSK, 노보노디스크, 리제네론, 로슈
- 3상모집 중· Alzheimers DiseaseA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
리드: 로슈
- 2상모집 중· Acute Respiratory Distress Syndrome (ARDS)JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
협력: 로슈
- 3상모집 중· Non-Small Cell Lung CancerA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
리드: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.